SEC Form 4 · accession 0001534424-15-000457

ClearPoint Neuro, Inc. · CLPT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Dec 18, 2015

Accepted (ET)

Dec 21, 2015 · 4:50 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001285550

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Dec 18, 2015	P$0	77,017	—	A	110,005	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series A Warrants (right to buy)^F1,F2	$0.4058	Dec 18, 2015	P	30,807	A	Dec 18, 2015	Dec 18, 2020	Common Stock	30,807	30,807	D
Series B Warrants (right to buy)^F1,F2	$0.5275	Dec 18, 2015	P	23,106	A	Dec 18, 2015	Dec 18, 2020	Common Stock	23,106	23,106	D

F1The reported securities are included within 77,017 units purchased by the Reporting Person for $0.3246 per unit. Each unit consists of one share of common stock, one series A warrant to purchase 0.40 share of common stock, and one series B warrant to purchase 0.30 share of common stock.
F2The shares subject to this warrant are immediately exercisable.